Commons Sense

House of Commons · Ministers' Questions

Antimicrobial Resistance

Tuesday 10 March 2020 · 1 question

Summarised by AI from the official record, so it can contain mistakes.

Read the full transcript on Parliament.uk

At a glance

Answered 1 Partly answered 0 Not answered 0

Key points

  • David Davis questions the Department's level of work and research regarding novel approaches to antimicrobial resistance, given the potential mortality estimates.
  • Matthew Hancock acknowledges the significant threat posed by antimicrobial resistance, comparing it to the risk from viral diseases.
  • Hancock confirms ongoing investments in addressing antimicrobial resistance and indicates plans for further investment.

Topics (select to filter)

Questions & Answers

Q1 David Davis Con Haltemprice and Howden
NHS
Context

The UK is a world leader in tackling the global challenge of antimicrobial resistance, having invested £615 million since 2014.

Question

David Davis questions whether the Department's level of work and research regarding novel approaches like genomics, combination drugs, and new vaccinations matches the threat posed by AMR, given estimates that up to 10 million people could die annually from it by 2050.

Answer from The Prime Minister Matthew Hancock

Matthew Hancock acknowledges the threat posed by AMR, stating that microbial illness and disease are as significant a risk as viral diseases. He confirms ongoing investments and indicates more to come.

Answered
Was this summary accurate? Tell us

How accurate was this summary? (1 = poor, 5 = spot on)